Apoptosis of peripheral CD4++ T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies

Renal Failure

Volumn 33, Issue 2, 2011, Pages 138-143

  Borges, Ana ^a   Borges, Margarida ^a,b   Fernandes, João ^c   Nascimento, Henrique ^a,b   Sameiro Faria, Maria ^d   Miranda, Vasco ^d   Reis, Flávio ^e   Belo, Luis ^a,b   Costa, Elisio ^b,f   Santos Silva, Alice ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^d FRESENIUS MEDICAL CARE PORTUGAL   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

^f CBQF CENTRO DE BIOTECNOLOGIA E QUÍMICA FINA LABORATÓRIO ASSOCIADO   (Portugal)

Author keywords

apoptosis; end stage renal disease; hemodialysis; rhEPO therapy; T cell lymphopenia

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; IMMUNE SYSTEM; KIDNEY FAILURE; LYMPHOCYTOPENIA; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 79952000251     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.553300     Document Type: Article

References (23)

1. US Renal Data System, USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2009.
2. Krishnamurthy G, Kher V, Naik S. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells. Scand J Urol Nephrol. 2002;36:377-382. (Pubitemid 35373627)
3. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet. 1999;354:93-99. (Pubitemid 29313142)
4. Selroos O, Pasternack A, Virolainen M. Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. Clin Exp Immunol. 1973;14:365-370.
5. Costa E, Lima M, Alves JM, et al. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol. 2008;28:268-275.
6. Costa E, Rocha S, Rocha-Pereira P, et al. Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Am J Nephrol. 2008;28:935-940.
7. Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:204-212. (Pubitemid 34042029)
8. Litjens N, Druningen CJ, Betjes MGH. Progressive loss of renal function is associated with activation and depletion of naïve T lymphocytes. Clin Immunol. 2006;118:83-91. (Pubitemid 43012050)
9. Girndt M, Sester M, Sester U, Kaul H, Köhler H. Molecular aspects of T and B cell function in uremia. Kidney Int. 2001;59:206-211.
10. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711-2720. (Pubitemid 36857634)
11. + lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci. 2009;14:3771-3781.
12. - lymphocytes in the lung and blood of HIV-infected subjects. J Clin Immunol. 2005;117:294-301.
13. + T cells to CD3-mediated apoptosis. Clin Exp Immunol. 2004;139:268-278.
14. Calopa M, Bas J, Callén A, Mestre M. Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiol Dis. 2010;38:1-7.
15. Katz O, Lindor G, Lifshitz L, et al. Erythropoietin enhances immune responses in mice. Eur J Immunol. 2007;37:1584-1593. (Pubitemid 46939493)
16. Prutchi-Sagiv S, Neumann D, Mittelman M. Erythropoietin as an Immunotherapeutic agent: New uses for an old drug? Med Hypotheses Res. 2005;2:587-596.
17. Ueki Y, Nagata M, Miyake S, Tominaga Y. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin. J Clin Immunol. 1993;4:179-287.
18. Kurz P, Köhler H, Meuer S, Hütteroth T, Meyer Zum Büshenfeld KH. Impaired cellular immune responses in chronic renal failure: Evidence for a T cell defect. Kidney Int. 1986;29:1209-1214. (Pubitemid 16094235)
19. Yoon JW, Gollapudi S, Pahl MV, Vaziri ND. Naïve and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 2006;70:371-376. (Pubitemid 44086588)
20. Sardenberg C, Suassuna P, Andreoli MCC, et al. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant. 2006;21:160-165. (Pubitemid 43057125)
21. Carracedo J, Ramírez R, Soriano S, Martín-Malo A, Rodríguez M, Aljama P. Caspase-3-dependent pathway mediates apoptosis of human mononuclear cells induced by cellulosic hemodialysis membranes. Nephrol Dial Transplant. 2002;17:1971-1977. (Pubitemid 35277096)
22. + T cells and their association with HIV-1-induced T cell dysfunction. J Immunol. 2005;175:8415-8423.
23. Trzonkowski P, Debska-Slizien A, Szmit E, et al. Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in hemodialysis patients. Nephrol Dial Transplant. 2005;20:367-376. (Pubitemid 40282541)